Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2022 Jan 14;11:840551. doi: 10.3389/fonc.2021.840551

Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Jun Li 1,2,, Sile Han 1,, Cuiyun Zhang 1,2, Yanlin Luo 3, Li Wang 3, Ping Wang 4, Yi Wang 5, Qingxin Xia 5, Xiaoyan Wang 1,2, Bing Wei 1,2, Jie Ma 1,2, Hongle Li 1,2,*, Yongjun Guo 1,2,*
PMCID: PMC8796203  PMID: 35096631

In the original article, we neglected to include the funder National Natural Science Foundation of China, 81802779 to Jun Li; Henan Provincial Health Commission, SBGJ202002020 to Jun Li; and Henan Science and Technology Project, 212102310675 to Jun Li.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES